Discover the full record of transactions filed by 李叶, Membre du Conseil. Insider active across 1 companies, notably 昭衍新药. In total, 44 disclosures have been logged. The latest transaction was filed on 30 September 2025 — Sale. Regulator: AMF. The full history is openly available.
李叶 is a Board Member at 昭衍新药. In this role, he contributes to overseeing the company's activities and strategic decision-making. 昭衍新药 is an innovative pharmaceutical company, and 李叶's expertise is essential for its development.